Cost-effectiveness model for colon cancer screening.
OBJECTIVE
The relative efficacy and effectiveness of different colon screening programs has not been assessed. The purpose of this analysis was to provide a model for comparing several colon screening programs and to determine the key variables that impact program effectiveness.


METHODS
Five screening programs were compared: annual fecal occult blood test (FOBT) alone, flexible sigmoidoscopy, flexible sigmoidoscopy and FOBT combined, one-time colonoscopy, and air-contrast barium enema. Key variables were adjusted for sensitivity analyses. Cost-effectiveness was defined as the cost per cancer death prevented.


RESULTS
FOBT alone prevents fewer cancer deaths than the other programs. The addition of flexible sigmoidoscopy to the FOBT increases the rate of cancer prevention. One-time colonoscopy has the greatest impact on colorectal cancer mortality, largely because of assumptions that cancer would be prevented in most patients who undergo polypectomy. FOBT alone is the most cost-effective of the programs, but the cost is sensitive to several key variables.


CONCLUSIONS
The model shows key variables that impact the cost-effectiveness of colon screening programs. Compliance is an important determinant of effectiveness of all of the screening programs. Future study should be focused on methods of patient education that improve patient compliance with screening.
D000368:Aged; D001466:Barium Sulfate; D003110:Colonic Neoplasms / Q000401:mortality / Q000517:prevention & control*; D003113:Colonoscopy; D003362:Cost-Benefit Analysis; D004733:Enema; D006801:Humans; D008403:Mass Screening / Q000191:economics*; D008875:Middle Aged; D018803:Models, Economic; D009780:Occult Blood; D010349:Patient Compliance; D012680:Sensitivity and Specificity; D012812:Sigmoidoscopy
D001466:Barium Sulfate